Wedbush restated their outperform rating on shares of Novadaq Technologies Inc. (TSE:NDQ) in a research report sent to investors on Thursday. They currently have a C$17.00 price target on the stock.

Separately, Royal Bank Of Canada reissued an outperform rating on shares of Novadaq Technologies in a report on Thursday, July 7th.

Shares of Novadaq Technologies (TSE:NDQ) traded down 1.07% during trading on Thursday, reaching $14.77. 400 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $15.46 and its 200 day moving average price is $13.98. The firm’s market capitalization is $848.32 million. Novadaq Technologies has a 52 week low of $10.81 and a 52 week high of $20.40.

About Novadaq Technologies

Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with's FREE daily email newsletter.